About US
Contact us
-
Shire disputes employee dissatisfaction report as UBS slashes price targetShire may have been plenty happy to finallylandlongtime buyout target Baxalta last year. But since then, its staffers haven’t been quite so pleased. Parsing 20,000 employee reviews from career websit2017/8/31
-
FDA blesses nonprofit-backed Chagas drug, thwarting ex-Shkreli biotech’s bid for rival launchMarking a dramatic step for a partnership aimingto affordably treat Chagas patients, the FDAapprovedthe group's antiparasitic treatment benznidazole. But the approval is an equally dramatic setbackfor2017/8/31
-
Sanofi veteran Peter Guenter exits top diabetes role to take helm at AlmirallSanofi’s loss is Almirall’s gain. The French drugmaker’s global diabetes and cardiovascular chief, Peter Guenter, has decamped for the top job at Almirall, a Spanish pharma that specializes in dermato2017/8/30
-
FDA refuses Acorda NDA for Parkinson's drug candidate because of manufacturing issuesWith generics threatening its main moneymaking medication, and an investor threatening its independence, Acorda Therapeutics has been pinning its hopes on approval of a new Parkinson’s disease drug. B2017/8/30
-
Havas Health quietly picks up Bristol-Myers Squibb's media business after Sanofi retention winThe new Havas Health & You is off to a solid start, especially considering the general downturn in the ad agency business for the first half of 2017. The business unit,createdin March by the combi2017/8/29
-
Novartis meeting, prior to CAR-T approval, leaves cancer patient concerned about pricingDavid Mitchell was pleasantly surprised when Novartis’ oncology chief, Bill Hinshaw, accepted his request for a meeting to discuss what a fair price might be for tisagenlecleucel (CTL019), its upcomin2017/8/29
-
SNL veteran Vanessa Bayer joins Allergan for birth control Q&A on streets of NYCIt wasn’t all that long ago that Allergan unveiled a purple-haired, fashion-forward cartoon as the face of its birth control awareness efforts. With its latest campaign, though, it’s going a little mo2017/8/28
-
Shire tweaks popular hemophilia app platform to serve hard-to-treat patientsShire last week moved to help hemophiliacs with inhibitors better manage their disease digitally. The pharmastrucka deal with independent hemophilia platform MicroHealth tocustomize its existing app t2017/8/28
-
HPV vaccination rates ticking upward, CDC says as it urges more uptakeEfforts to boost the national HPV vaccination rate are yielding some positive results, new data from the CDC show. Nationwide, 60% of teens ages 13 to 17 received at least one dose of the shot last ye2017/8/27
-
FDA targets rogue clinic using Sanofi's smallpox vaccine in unapproved cancer therapyAs part of a recent crackdown on stem cell clinics, the FDA found an operation using Sanofi's smallpox vaccine in an illegitimate cancer therapy. U.S. Marshals seized five vials of the vaccine, a con2017/8/27